Dendritic cells (DCs) are key participants in innate and adaptive immune responses 1 . The prevalent model of DC migration is an unidirectional pathway whereby precursor DCs arise from progenitors in the bone marrow, enter the blood and traffic into secondary lymphoid organs and peripheral tissues, such as skin or gut 2 , where they contribute to the front line of defense against pathogens. When DCs encounter inflammatory stimuli, they undergo a switch in chemokine receptor expression, enabling their egress into lymphatic vessels and transport to draining lymph nodes 3 . Maturing DCs also become fully immunostimulatory by upregulating major histocompatibility complex (MHC) and costimulatory molecules to prime naive T cells.
Normal peripheral blood contains some immature DCs, which capture blood-borne bacteria and transport them to the spleen 4 . However, whether these DCs originate directly in the bone marrow or reenter the blood after migrating within other tissues is unclear. There is ample experimental evidence that draining lymph nodes are the terminal targets for most DCs that leave peripheral tissues. However, a few observations suggest that tissue-resident DCs can somehow return to the blood and carry antigen to organs other than lymph nodes. For example, DCs carry fluorescent beads, dyes or antigen to the spleen after either intracutaneous injection or instillation into the lung [5] [6] [7] . However, whether and to what extent blood-borne DCs carry antigen to other tissues is unclear. This question has clinical relevance, as in cancer vaccine trials, autologous DCs modified ex vivo have been infused into patients 8 . The migration of DCs to nonlymphoid organs might be advantageous for 'boosting' memory responses to previously encountered pathogens, as antigen-experienced T cells disseminate to many nonlymphoid tissues 9 . Different organs contain T cells with distinct functional properties. The bone marrow is particularly notable in this; CD8 + memory cells in bone marrow undergo more vigorous homeostatic proliferation and respond faster to antigen stimulation than those in other tissues 10, 11 . The bone marrow actively accumulates CD8 + central memory T cells (T CM cells), which are more frequent among T cells in the bone marrow than elsewhere 12 . In cancer patients, memory T cells in the bone marrow have greater antitumor reactivity than do peripheral blood memory cells 13 . However, it is unclear whether and how recall antigen from tumors or pathogens gains access to the bone marrow.
Here we report that small numbers of DCs traffic constitutively from peripheral tissues to blood. Moreover, circulating DCs have considerable bone marrow tropism. Using intravital microscopy in mouse skull bone marrow, we show that homing of DCs to the bone marrow depended on microvascular P-selectin and E-selectin as well as vascular cell adhesion molecule 1 (VCAM-1). Once in the bone marrow, DCs induced rapid proliferation of antigen-specific T CM cells. Using two-photon intravital microscopy to visualize T cell receptor (TCR)-transgenic T CM cells and DCs that had homed to bone marrow cavities, we found that both cell types rarely interacted in the absence of antigen, whereas antigen-presenting DCs rapidly formed stable conjugates with T CM cells. These data suggest a pathway for DC migration that allows DCs to collect antigen in peripheral sites and then traffic to the bone marrow to elicit recall responses by resident T CM cells.
RESULTS

In vivo migration pathways of DCs
Our first objective was to elucidate the trafficking routes of differentiated DCs after adoptive transfer into the circulation of normal mice. To obtain a sufficiently large number of DCs for these experiments, we expanded DC populations in vivo by implanting donor mice with tumors secreting the ligand for the cytokine receptor Flt3 (refs. 14,15) . At about 2 weeks after tumor implantation, donor splenocytes yielded large numbers of CD11c + cells representing every conventional DC subset 15 . Donor DCs uniformly displayed an immature phenotype (MHC class II int , CD80 lo , CD86 lo and CCR7 lo ). Maturation was induced by 24-48 h of culture in lipopolysaccharide (LPS), as demonstrated by upregulation of MHC and costimulatory molecules ( Table 1) .
After injecting tail veins, we analyzed the distribution of donor DCs in recipient blood and tissues by flow cytometry (Fig. 1a) . At 2 h after injection of both immature and mature DCs (Fig. 1b) , we recovered the largest numbers from the liver, followed by the lung and the spleen. At 24 h after injection (Fig. 1b) , immature DCs were retained to a greater extent than mature DCs in the liver, while the number of immature and mature DCs in the lung had dropped by 90% and 95%, respectively. Unexpectedly, there was also substantial accumulation of preferentially immature DCs in the recipients' bone marrow. At 2 h after injection, the number of immature and mature DCs in the bone 16 . We noted equivalent patterns of DC distribution when we injected nonfluorescent CD45.2 + DCs intravenously into congenic CD45.1 + recipients (Fig. 1a) and when we obtained DCs from donors without Flt3 ligand-secreting tumors (data not shown), indicating that DC trafficking was not affected by the labeling procedure or by cytokine-induced expansion. Adoptive transfer of DCs (C57BL/6) into allogeneic (BALB/c or FVB) recipients yielded similar results (data not shown), indicating that DC recruitment was independent of the recipient's genetic background.
Subset-specific recruitment of circulating DCs Differential expression of CD8a identifies discrete DC subsets with distinct migratory and functional properties as well as tissue distribution 17 . Thus, we sought to determine whether there were subsetspecific differences in trafficking after intravenous injection. At 2 h after transfer of input cells comprising about 25% CD8a + DCs, the frequency of this subset among donor DCs was lower in peripheral blood and in all nonpulmonary recipient organs analyzed (Fig. 1c) . Conversely, CD8a + DCs represented 38% of donor-derived DCs in the lung, suggesting that these relatively large cells are preferentially trapped in pulmonary capillaries. However, the ratio of CD8a + to CD8a À DCs in nonpulmonary sites, including the bone marrow, was similar to their ratio in blood, suggesting that CD8a + and CD8a À DC subsets migrate equivalently once they have passed the pulmonary 'sieve' . These experiments suggested that DC recruitment to noninflamed peripheral organs other than the lung is governed by tissue-specific factors regardless of the DC maturation state or subset membership. However, the retention and/or survival of DCs depends on their maturation state and the tissue environment, which seems especially favorable for immature DCs in the bone marrow.
DCs reach the bone marrow from peripheral tissues Having determined that circulating DCs have bone marrow tropism, we sought to determine whether DCs can reach the bone marrow from peripheral sites. Thus, we labeled immature DCs with carboxyfluorescein succinimidyl ester (CFSE), deposited 2 Â 10 6 to 8 Â 10 6 of the DCs in both footpads and monitored their appearance in the draining popliteal lymph nodes, blood, spleen and bone marrow. When DC maturation was induced by simultaneous injection of 10 ng LPS, large numbers of DCs migrated to the popliteal lymph nodes, but even without LPS, a few DCs appeared within 24 h in the popliteal lymph nodes, and this population increased considerably at 48 h (Fig. 2a,b) . The transferred immature DCs were almost undetectable in blood, spleen and bone marrow after 24 h. However, labeled DCs were readily recoverable from all three tissues at 48 h. Maturation accelerated DC dissemination from the footpad, as we recovered substantial numbers from blood, bone marrow and spleen as early as 24 h after injection.
Constitutive trafficking via blood to bone marrow As immature DCs are present in normal peripheral blood 18 , we sought to determine whether these endogenous DCs migrate to the bone marrow. We surgically joined CD45.1 + and CD45.2 + congenic mice at the flanks, which results in a shared circulation within 3 d. We then screened the bone marrow of parabiotic mice for partnerderived leukocytes 19 .
We collected bone marrow 3-15 d after surgery, and in one experiment we separated mice 28 d after parabiosis and analyzed bone marrow 28 d later. As soon as a shared circulation was established, partner-derived leukocytes appeared in the bone marrow of these parabiotic mice (Fig. 2c) . At 5 d after surgery, 1% and 1.9% of DCs in the bone marrow were partner derived in CD45.2 and CD45.1 hosts, respectively (Fig. 2c) . By day 15, the average frequency of bone marrow-resident partner-derived DCs was 7%. Consistent with the short lifespan of DCs 20 , partner-derived DCs persisted poorly after separation. Nonetheless, it is likely that at later time points some of the partner-derived CD11c + arose from precursor cells that had homed to the bone marrow 19 . However, the rapid kinetics with which DCs became detectable after parabiosis indicate that full-fledged DCs migrate constitutively to normal bone marrow.
Thoracic duct lymph contains DCs
Having determined that a stream of circulating endogenous DCs enters the bone marrow, we sought to determine whether tissueresident DCs also enter the bone marrow. Such peripheral DCs might enter draining lymphatics and bypass or traverse 'downstream' lymph nodes to reach the circulation via the thoracic duct. Indeed, thoracic duct lymph fluid from normal mice contained a small population of NK1.1 -CD11c + cells that constituted 0.013% ± 0.004% of viable cells ( Fig. 2d) , suggesting that a subtle, but continuous stream of DCs migrates from peripheral tissues through the lymph to the blood and from there to selected targets, including the bone marrow.
Molecular mechanisms of DC recruitment to bone marrow
Using intravital microscopy of mouse skull bone marrow 21 , we characterized the molecules that enable blood-borne DCs to adhere to bone marrow microvessels. Both immature and mature DCs engaged in rolling in bone marrow venules and sinusoids ( Fig. 3a) , but immature DCs rolled more frequently than mature DCs (25.2% ± 1.4% versus 15.3% ± 1.3%, respectively; P o 0.05). There was no difference in the frequency with which rolling cells arrested (Fig. 3b) .
Injection of antibody to P-selectin (anti-P-selectin) reduced DC rolling by more than 50%. Even more inhibition was achieved with combined anti-P-selectin and anti-E-selectin, although anti-E-selectin alone was ineffective (Fig. 3c) . VCAM-1 is constitutively expressed in bone marrow microvessels and mediates firm adherence of hematopoietic progenitors in skull bone marrow 21 . The main ligand for VCAM-1, the integrin a 4 b 1 (VLA-4), is expressed on immature and mature DCs ( Table 1) . DC Rolling and sticking fractions in VCAM-1-deficient mice were normalized to those of wild-type littermates. Ab, monoclonal antibody; E-sel, E-selectin; P-sel, P-selectin. *, P o 0.05, **, P o 0.01).
1 0 3 2 VOLUME 6 NUMBER 10 OCTOBER 2005 NATURE IMMUNOLOGY sticking was significantly reduced by treatment with antibody to the a 4 integrin chain and in VCAM-1-deficient mice (P o 0.01; Fig 3d) . Thus, circulating DCs interact with the two endothelial selectins to roll and with VCAM-1 to arrest in normal bone marrow microvessels. Notably, although firm arrest on VCAM-1 presumably required that the rolling DCs receive a chemoattractant signal that activates a 4 b 1 , DC sticking was unaffected after Ga i protein blockade with pertussis toxin (data not shown). Moreover, DC sticking was not reduced by antibody to the integrin a L b 2 (LFA-1), which mediates leukocyte arrest in other microvascular beds 16 and is abundantly expressed on DCs ( Table 1) . The recruitment signals for bone marrow-tropic DCs are thus very similar to the multistep adhesion cascade that mediates homing of hematopoietic progenitors and T CM cells to the bone marrow 12, 21 .
DCs can activate bone marrow-resident T CM cells
To determine whether blood-borne DCs could trigger immune responses after homing to the bone marrow, we intravenously injected CFSE-labeled DCs and then sorted them from recipient organs 24 h later. Recovered DCs from bone marrow and spleen were as potent as freshly isolated splenic DCs at stimulating allogeneic T cells (data not shown). Thus, homing does not alter the immunostimulatory capacity of DCs. Next we sought to determine whether DCs can transport and present antigen to T CM cells, which represent the principal subset among human and mouse bone marrow-resident T cells 12 . We obtained CD8 + T cells from mice carrying the P14 TCR transgene and differentiated the TCR-transgenic CD8 + T cells into T CM -like cells using established tissue culture methods 22 . T CM cells differentiated in vitro have homing characteristics equivalent to those of endogenous T CM cells 23 , migrate avidly to the bone marrow 12 and are readily restimulated by recall antigen 22 . Accordingly, P14 T CM cells proliferated vigorously during coculture with mature and, to a lesser extent, immature DCs that had been pulsed with specific peptide antigen (lymphocytic choriomeningitis glycoprotein 33-41 (gp33)) but not those pulsed with irrelevant peptide antigen (lymphocytic choriomeningitis nucleoprotein 396-404 (np396)) (Fig. 4a) .
To determine whether DCs could also stimulate bone marrowresident T CM cells in vivo, we injected 5 Â 10 6 to 7 Â 10 6 CFSE-labeled P14 T CM cells intravenously into recipient mice, then allowed the mice to 'rest' for 24 h. We then intravenously injected 3 Â 10 6 to 5 Â 10 6 immature or mature DCs pulsed with gp33 or control peptide. Then, 2 d later, we collected T CM cells from various organs and analyzed them for CFSE dilution, a measure of proliferation. As expected, T cells did not divide in mice injected with np396-pulsed DCs (Fig. 4b) , whereas gp33-pulsed DCs elicited vigorous T cell proliferation in spleen, liver and bone marrow (Fig. 4c) . By 42 h after mature DC injection, T CM cells had divided four to five times in these organs; in recipients of immature DCs, T CM cells had also divided, but their division lagged behind that of cells stimulated with mature DCs by about half a division. Regardless of the maturation state of the injected DCs, few T CM cells proliferated in lymph nodes, which is consistent with the inability of circulating DCs to home to these organs 24 .
To exclude the possibility that the divided T CM cells found in DCchallenged bone marrow had homed there after having received activation signals elsewhere, we collected organs early (17 h) after DC injection, before any T CM cells had a chance to divide (Fig. 4d) . We then maintained single-cell suspensions of collected tissues in vitro. After 2 d in culture, vigorous T cell proliferation was apparent in both spleen and bone marrow cultures from recipients of gp33-pulsed DCs. This effect was antigen specific, as tissue cultures from mice that had received control peptide-pulsed DCs contained only undivided T CM cells. Lymph node cultures from recipients of gp33-pulsed DCs showed no T CM cell proliferation, suggesting that the few divided cells in lymph nodes collected 42 h after DC injection had been stimulated elsewhere and subsequently migrated to lymph nodes through the blood. Conversely, T CM cell proliferation in early bone marrow cultures demonstrated that bone marrow-tropic DCs are immunocompetent. Thus, at least a fraction of the divided T CM cells found in bone marrow in vivo (Fig. 4b ) was most likely activated by DCs that had homed in situ.
Visualization of T cell-DC interactions in bone marrow
Having determined that circulating DCs can carry antigen to the bone marrow and potently stimulate antigen-specific responses by T CM cells, we sought to determine whether and how DCs and T CM cells interact in the bone marrow. For this, we used two-photon intravital microscopy of mouse skull bone marrow cavities 12 (Fig. 5a,b) . We labeled P14 T CM cells with the blue nuclear dye Hoechst 33342 and injected them intravenously into recipient mice. We labeled peptidepulsed DCs with CMTMR, a red-orange fluorophor, and injected them 12-16 h later. After 2 h, we prepared the mice for two-photon intravital microscopy as described 12 . We visualized the luminal compartment of bone marrow microvessels with fluorescein isothiocyanate-dextran and acquired three-color fluorescence image stacks over 30 min (1 stack/min) to record three-dimensional time-lapse videos of extravascular T CM cell-DC interactions.
With no antigen present, both DCs and T CM cells showed continuous random movements throughout the bone marrow cavity (Supplementary Video 1 online) , and most contacts between DCs and T CM cells were brief, although about one in four T CM cells remained associated with DCs throughout the observation period (Fig. 5c) . However, most antigen-independent prolonged contacts were not associated with a change in the shape of the T cells, whereas P14 T CM cells polarized to undergo tight, long-lasting contacts with a broadened interface with gp33-pulsed DCs (Fig. 5b,c and Supplementary Video 2 online). The presence of antigen also resulted in a decrease in T CM cell instantaneous velocity, whereas DCs migrated slowly whether they presented cognate antigen to T CM cells or not (Fig. 5d) . This was also reflected in the mean square displacement plots (a measure of cell motility 25 ), which showed a notable antigen-dependent suppression in the motility of T CM cells (Fig. 5e) but not of DCs (Fig. 5f ).
DISCUSSION
We conceived this study with the objective of better defining the target organs of circulating DCs. It is already well established that tissueresident DCs continuously sample antigen in peripheral tissues and carry it to draining lymph nodes, where they present it to recirculating T cells 1 . A small fraction of DCs from certain peripheral tissues can relocate to distant secondary lymphoid organs that are not connected by lymphatics, indicating that some tissue-resident DCs can return to the blood [5] [6] [7] . Those observations indicate that blood-borne DCs may be highly migratory and may comprise more than one subset distinguished by different histories and perhaps destined for distinct target tissues 18, 26, 27 . However, the present understanding of blood-borne DC trafficking is based mainly on comparisons of DC vaccines administered by different routes 8 . In addition, it is known that blood-borne DCs migrate to inflamed tissues 28 , but the paths taken by circulating DCs in the absence of inflammation are still poorly understood.
Our initial strategy was to inject labeled primary DCs into mice to track their migration. However, the number of true DCs that can be routinely collected from normal mice is prohibitively small for in vivo trafficking studies. To overcome this obstacle, we implanted donor mice with a melanoma secreting Flt3 ligand, which substantially increased production of all DC subsets without perturbing their function 14, 15 . When we intravenously injected purified DC populations expanded by Flt3 ligand, they migrated preferentially to the liver, lung and spleen but were excluded from all other secondary lymphoid organs, consistent with published observations 24, [29] [30] [31] . The inability of 12, 21, 32 . Indeed, homing of DCs to the bone marrow depended on rolling mediated by P-selectin (and E-selectin), followed by VCAM-1-dependent sticking. Notably, the number of DCs that homed to bone marrow was comparable to that in the spleen, and the bone marrow retained DCs even better than the spleen after 24 h. One caveat was that the injection of supraphysiological numbers of DCs could have saturated the sites at which DCs normally exit the circulation, resulting in abnormal spillover to the bone marrow. Therefore, we studied DC migration in parabiotic mice. In these experiments, partner-derived DCs were detectable in the bone marrow with kinetics that were much more rapid than the slow differentiation of DCs from progenitors 26 . We conclude that substantial numbers of full-fledged DCs continuously access normal bone marrow from the blood.
What are the functional consequences of this migratory pathway? The bone marrow can function as a secondary lymphoid organ in virus-infected mice in which lymphocytes cannot traffic to secondary lymphoid organs 33 . Thus, the bone marrow provides a suitable microenvironment for T cell priming. Homing of immature DCs to the bone marrow could contribute to this function by supplying highly phagocytic cells that may collect antigen locally. Additionally, DCs can capture antigen in the blood and subsequently migrate to extravascular sites to prime lymphocytes 4 .
Although the physiological function of the bone marrow during T cell priming is still being debated, there is mounting evidence that the bone marrow is involved in recall responses and memory T cell homeostasis 33 . Indeed, viral infections induce the formation of T CM cells that are particularly important for long-term protection 34 . These cells preferentially accumulate and proliferate in the bone marrow and mount stronger effector responses than the corresponding population in the blood 33 . Moreover, evidence has suggested that optimal preservation of CD8 memory requires the presence of DCs 35 . Given those findings, we hypothesized that DCs could traffic to the bone marrow to trigger recall responses by bone marrow-resident T CM cells.
As predicted, DCs that had homed efficiently to bone marrow stimulated bone marrow-resident T CM cells. In contrast to results with naive T cells, which are only activated by mature DCs, T CM cell proliferation was readily noted with immature DCs. This is consistent with the lower costimulation requirements for memory T cell activation than for naive T cells 9 . Another difference between naive T cells and T CM cells was suggested by our two-photon microscopy experiments; as early as 2 h after DC injection, almost all T CM cell-DC interactions were manifested as tight, long-lasting conjugates. In contrast, two-photon intravital microscopy of naive T cell priming with the same peptide antigen in lymph nodes showed that there was an initial phase of about 8 h during which T cells touched antigen-presenting DCs only briefly. Tight contacts were found only thereafter 36 . The faster kinetics of stable conjugation in the bone marrow might reflect the enhanced susceptibility of T CM cells to recall antigen. Alternatively, the bone marrow microenvironment may foster T cell-antigen-presenting cell interaction kinetics different from those of peripheral lymph nodes.
An important issue was whether tissue-resident DCs can collect antigen and then migrate to the bone marrow through the blood.
It seemed plausible that such peripheral DCs might enter local lymphatics and bypass or traverse 'downstream' lymph nodes to reach the circulation through the thoracic duct. Consistent with that idea, we found that thoracic duct lymph fluid in normal mice contained a small DC population that comprised 0.013% ± 0.004% viable cells. Assuming a leukocyte flux of about 7 Â 10 6 cells/h through the thoracic duct of an adult mouse 37 , we calculate that at least 2.2 Â 10 4 peripheral DCs return to the circulation via this route every day. Only a fraction of this population is likely to migrate to the bone marrow, whereas our results in parabiotic mice indicated that at least 3 Â 10 4 partner-derived DCs enter the bone marrow every day. Therefore, DCs can probably also reach the blood-bone marrow conduit via routes other than lymphatics.
Indeed, whereas the mechanisms that govern interstitial DC migration into draining lymph vessels are partially understood, it is unclear whether this is the only route by which DCs leave tissues. For example, high endothelial venules and chronically inflamed microvessels express CCL21, a ligand for CCR7, which mediates lymphocyte traffic in secondary lymphoid organs and is also required for DC migration into lymph vessels 38 . It is conceivable that CCR7 + DCs could enter the bloodstream by migrating across CCL21 + venules. Indeed, monocyte-derived DCs can undergo reverse transmigration, whereby they cross an endothelial monolayer from the extravascular compartment to the lumen 39 .
The suggestion that tissue-resident DCs could reach the blood and then migrate to other organs has surfaced repeatedly in the literature but has not been addressed systematically. DCs carry fluorescent beads, dyes or antigens to the spleen after either intracutaneous injection or instillation into the lung [5] [6] [7] 40, 41 . Those cells could only reach the spleen by re-entering the circulation. Similarly, after solid organ transplantation, graft-derived DCs appear rapidly in the recipient's blood and spleen 42, 43 . Finally, CD18 + leukocytes, including CD11c + DCs, collect Salmonella typhimurium from the intestinal lumen and then appear in the blood as early as 15 min after intragastric infection 44 . We have done similar experiments by infecting mice orally with invasion-deficient S. typhimurium. At 30-60 min after infection, we detected small numbers (10-20 colony-forming units/ ml) of bacteria in peripheral blood. By 24-36 h after infection, we were able to culture bacteria from the bone marrow (30-1,120 colonyforming units/whole bone marrow) and the spleen (150-9,700 colonyforming units/spleen). Indeed, using green fluorescent protein-tagged S. typhimurium, we detected green fluorescent protein-positive DCs in the spleen and bone marrow of infected mice (unpublished data).
Our results provide evidence for a migratory route that channels DCs from peripheral tissues. Whereas the number of DCs that could be recovered from the bone marrow was 3-10% of what was found in the draining lymph nodes, the relatively small number of migrating DCs might well be sufficient to elicit substantial immune responses by the highly reactive memory T cell population that is prevalent in the bone marrow. After deposition in the footpad, equivalent numbers of immature and mature DCs were recovered from the bone marrow, although the former migrated more slowly than the latter. This maturation-dependent difference in migratory kinetics indicated that the departure of DCs from peripheral tissues is an active process and is not simply a consequence of the sudden increase in interstitial pressure caused by cell injection.
Our findings demonstrate that small numbers of DCs continuously leave peripheral tissues and gain access to the bloodstream via the thoracic duct. Using adoptive transfer protocols and several approaches to trace endogenous DCs, we have shown that bloodborne mature and immature DCs home to normal bone marrow through a multistep cascade that involves P-selectin and E-selectin as well as VCAM-1. Our experimental data suggest that DCs can take this previously unknown migration route to induce rapid antigen-specific activation of bone marrow-resident CD8 + T CM cells as a truly central memory response.
METHODS
Mice. C57BL/6 (CD45.2/Ly5.2), congenic CD45.1/Ly5.1 (B6.SJL-Ptprc a Pep3 b / BoyJ), FVB and BALB/c mice were purchased from Jackson Labs, Taconic or Charles River Laboratories. P14 transgenic mice 45 were obtained from Jackson Labs. Mice with conditional deficiency of VCAM-1 in the endothelium were generated as described 46 . All mice were housed and bred in a specific pathogenfree and viral antibody-free animal facility. All experiments were done in accordance with National Institutes of Health guidelines and were approved by Committees on Animals at both Harvard Medical School and the CBR Institute (Boston, Massachusetts).
Reagents. The lymphocytic choriomeningitis virus gp33 (KAVYNFATC) and np396 (FQPQNGQFI) peptides were synthesized at Biosource International.
Antibodies. For intravital microscopy, monoclonal antibodies to P-selectin (clone 5H1) and E-selectin (9A9) were provided by B. Wolitzky (Hoffman LaRoche, Nutly, New Jersey); monoclonal antibodies to CD11a (TIB213) and the integrin chains a 4 (PS/2) and b 7 (FIB504) were a gift from E. Butcher (Stanford University, California). Monoclonal antibody to the integrin chain b 2 (GAME-46) was purchased from Pharmingen.
For flow cytometry, fluorochrome-labeled monoclonal antibodies were purchased from Pharmingen. Expression of P-selectin ligands was detected with P-selectin-immunoglobulin (Pharmingen). CCR7 expression was measured by the binding of CCL19-immunoglobulin 23 . Data were acquired with a FACSCalibur flow cytometer and were analyzed with CellQuest software (BD Biosciences).
Cell preparation. Splenic DCs were isolated from C57BL/6 mice injected subcutaneously 11-14 d before with 4 Â 10 6 Flt3 ligand-secreting B16 tumor cells. For homing assays, total splenocyte samples were enriched for DCs by density gradient centrifugation over Optiprep (Sigma-Aldrich) and the low-density cells were collected. DC-enriched preparations routinely contained 75-85% CD11c + DCs. For intravital microscopy, CD11c + DCs were purified by positive selection with anti-CD11c microbeads (greater than 95% CD11c + ; Miltenyi Biotec). DC maturation was induced by culture for 24-48 h in the presence of 1 mg/ml of LPS (E.coli 0.26:B6; Sigma) or by simultaneous injection of 10 ng LPS/footpad. T CM cells were generated in vitro using established techniques 22 .
Homing assays. DCs were labeled for 20 min at 371 C with 30 mM CFSE (5(6)-carboxyfluorescein succinimidyl ester; Molecular Probes). Recipient mice were injected intravenously with 2 Â 10 7 to 5 Â 10 7 DCs. In some experiments, 2 Â 10 6 to 8 Â 10 6 DCs were injected subcutaneously into both footpads instead. After 2-48 h, recipient mice were killed and blood and other organs were collected and processed to single-cell suspensions. Livers and lungs were first digested with collagenase type 2 (0.5%; Worthington Biochemical). Bone marrow was collected from tibias and femora of hind legs, which accounts for about 20% of total body bone marrow 47 . Cells that had homed were identified as DCs by CD11c staining.
Cannulation of the thoracic duct. C57BL/6 mice were fed 700 ml of olive oil by gavage. Then, 45 min later, mice were anaesthetized by intraperitoneal injection of ketamine (50 mg/kg) and xylazine (10 mg/kg) and were subjected to laparotomy. A heparinized PE-10 polyethylene catheter was inserted into the cysterna chyli 48 and lymph was collected for 30-45 min, stained with monoclonal antibodies and analyzed by flow cytometry.
Intravital microscopy. Intravital microscopy of mouse cranial bone marrow microcirculation was done as described 21 . Boluses of DCs labeled with calceinacetoxymethyl ester (Molecular Probes) were injected into the carotid artery in a retrograde direction. Cells that entered the bone marrow microvasculature were visualized by video-triggered stroboscopic epi-illumination (Chadwick Helmuth) through a fluorescein isothiocyanate filter set. Video images were recorded with a low-lag silicon-intensified target camera (VE1000-SIT; Dage MTI), a time-base generator (For-A) and a Hi8 VCR (Sony). Cell activity was determined by offline analysis. The rolling fraction per venule was measured as the percentage of DCs that interacted with the vascular wall of total fluorescent cells that passed through the vessel during the observation period. The sticking fraction was defined as the percentage of rolling cells that became firmly adherent for 30 s or more.
Parabiotic mice. Pairs of parabiotic mice consisting of one CD45.1 and one CD45.2 congenic mouse were prepared as described 19 . Pairs of mice were analyzed between 3 and 28 d after parabiosis. One pair of mice was surgically separated after 28 d and was analyzed 28 d later.
In vivo antigen presentation. Mice were injected intravenously with 5 Â 10 6 to 7 Â 10 6 CFSE-labeled P14 T CM cells. Then, 24 h later, the same mice were injected intravenously with 3 Â 10 6 to 5 Â 10 6 peptide-pulsed DCs (5 mg/ml for 2 h at 37 1C). After a further 42-48 h, organs were collected and single-cell suspensions were stained for the P14-specific TCR V a 2. In some experiments, mice were killed 17-18 h after DC injection, organs were collected and unpurified single-cell suspensions were cultured without additional cytokines for up to 3 d. Proliferation was assessed by CFSE dilution as described 49 .
Two-photon microscopy. For two-photon imaging, P14 T CM cells were labeled for 20 min at 37 1C with Hoechst 33342 (10 mg/ml; Molecular Probes) before intravenous injection into recipient mice. Then, 16-18 h later, mice were injected intravenously with DCs labeled with 10 mM CMTMR (5-and-6, 4-chloromethylbenzoylamino tetramethylrhodamine; Molecular Probes). Imaging began approximately 2-3 h after injection of DCs. Mice were prepared for intravital microscopy imaging of the skull bone marrow as described 12 . Immediately before imaging, mice were injected with fluorescein isothiocyanate-dextran (2 MDa; Sigma) to visualize bone marrow vasculature. Twophoton imaging was done with an Olympus BX50WI fluorescence microscope equipped with a 20Â objective with a numerical aperture of 0.95 and a Radiance 2100MP Confocal/Multiphoton microscopy system, controlled by Lasersharp software (BioRad). For two-photon excitation, a MaiTai Broadband Ti:S laser (Spectra Physics) was tuned to 800 nm.
Three-dimensional analysis of cell migration has been described 12, 36 . Stacks of x-y sections were acquired every 30-60 s. Sequences of image stacks were transformed into volume-rendered four-dimensional movies with Volocity software (Improvision), which was also used for semiautomated tracking of moving objects. From centroid coordinates, parameters of cellular motility were calculated with custom scripts in Matlab (MathWorks) 50 .
Statistical analysis. All data are presented as mean ± s.e.m. Students' t-test was used for comparisons of two groups. In all cases, P values of less than 0.05 were considered statistically significant.
Note: Supplementary information is available on the Nature Immunology website.
